EpiBone

Epi Bone

Biotechnology, 760 Parkside Ave Ste 322, Brooklyn, New York, 11226, United States, 11-50 Employees

epibone.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 21********

Who is EPIBONE

EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the ...

Read More

map
  • 760 Parkside Ave Ste 322, Brooklyn, New York, 11226, United States Headquarters: 760 Parkside Ave Ste 322, Brooklyn, New York, 11226, United States
  • 2013 Date Founded: 2013
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies
  • Nina Tandon CEO:   Nina Tandon

industries-icon Industry: Biotechnology

SIC SIC Code: 3841 | NAICS Code: 339112 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from EPIBONE

EpiBone Org Chart and Mapping

Nina Tandon

Chief Executive Officer

Employees

Hyungjin Jung

Cartilage Tissue Engineer, Research Scientist

Julia Porrino

Quality Systems Engineer; Biomanufacturing

Huma Arastu

Senior Research Associate

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding EpiBone

Answer: EpiBone's headquarters are located at 760 Parkside Ave Ste 322, Brooklyn, New York, 11226, United States

Answer: EpiBone's phone number is 21********

Answer: EpiBone's official website is https://epibone.com

Answer: EpiBone's revenue is $1 Million to $5 Million

Answer: EpiBone's SIC: 3841

Answer: EpiBone's NAICS: 339112

Answer: EpiBone has 11-50 employees

Answer: EpiBone is in Biotechnology

Answer: EpiBone contact info: Phone number: 21******** Website: https://epibone.com

Answer: EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access